Future Perspectives of Rheumatoid Arthritis
Future Perspectives of Rheumatoid Arthritis tammytilley@gm… Thu, 09/11/2025 – 08:00 Rheumatoid Arthritis Anti-Rheumatic Rx Drug Safety Education/ACR/EULAR Novel Rx Dr. […]
RheumNow
RheumNow
AI can Dx & predict HCQ retinopathy (HR). An International, Multi-center study used retrospective data from 409 pts
AI can Dx & predict HCQ retinopathy (HR). An International, Multi-center study used retrospective data from 409 pts https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
QD Clinic: ILD, Emphysema, Both, or Neither? Dr. Janet Pope, London, Ontario discusses this case evaluation as part of
QD Clinic: ILD, Emphysema, Both, or Neither? Dr. Janet Pope, London, Ontario discusses this case evaluation as part of https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Gout: Highlights from APLAR 2025 Dr. Sheila Reyes, The Philippines, reports on highlights and takeaways from lectures
Gout: Highlights from APLAR 2025 Dr. Sheila Reyes, The Philippines, reports on highlights and takeaways from lectures https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
RheumNow
CAR T Cells are everywhere, whichever conference #APLAR25 an update on practicalities and safety measures and adverse ev
CAR T Cells are everywhere, whichever conference #APLAR25 an update on practicalities and safety measures and adverse ev https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
RheumNow
Dr. Binit Vaidya aptly poses this slide on the gout paradox: evidence-based T2T tx exist yet many still have uncontrolle
Dr. Binit Vaidya aptly poses this slide on the gout paradox: evidence-based T2T tx exist yet many still have uncontrolle
RheumNow
SGLT2 inhibitors exert their anti-inflammatory effects by inhibiting activation of the NLRP3 inflammasome. Secondary a
SGLT2 inhibitors exert their anti-inflammatory effects by inhibiting activation of the NLRP3 inflammasome. Secondary a https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Wed, 09/10/2025 –
RheumNow
Colchicine for #gout patients with CV risk: – since it has a purely anti-inflammatory effect, risk of acute CV events i
Colchicine for #gout patients with CV risk: – since it has a purely anti-inflammatory effect, risk of acute CV events
RheumNow
Addressing Disparities and Unequal Burdens in ILD Interstitial lung diseases (ILDs) represent a complex spectrum of co
Addressing Disparities and Unequal Burdens in ILD Interstitial lung diseases (ILDs) represent a complex spectrum of co https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
RheumNow
PAH diagnosis and management in the context of CTD ILD
PAH diagnosis and management in the context of CTD ILD aurelie.najm@g… Wed, 09/10/2025 – 13:28
RheumNow
Study of 111 TAKayasu arteritis pts Rx w/ 74 MMF+MTX vs 37 CYC/AZA. Response rates at 28 & 52 weeks were 58.1% and
Study of 111 TAKayasu arteritis pts Rx w/ 74 MMF+MTX vs 37 CYC/AZA. Response rates at 28 & 52 weeks
RheumNow
Long-term data from the 48-wk phase 2 SLEek study of upadacitinib +/- a BTK inhibitor elsubrutinib, in SLE pts, showed
Long-term data from the 48-wk phase 2 SLEek study of upadacitinib +/- a BTK inhibitor elsubrutinib, in SLE pts, showed
RheumNow
#APLAR2025 Prof Peter Taylor RA patients have ⬆️ rates of CKD https://t.co/DZl9qpbLhH
#APLAR2025 Prof Peter Taylor RA patients have ⬆️ rates of CKD https://t.co/DZl9qpbLhH https://pbs.twimg.com/profile_images/1528848092547715074/ne8WXmwU_normal.jpg john+RNV2@john… Wed, 09/10/2025 – 11:18 gurdeep_dulay Dr
RheumNow
Submit your #ACR25 late-breaking abstract by TOMORROW, Thurs., Sept. 11, at noon ET. Don’t miss the chance to share yo
Submit your #ACR25 late-breaking abstract by TOMORROW, Thurs., Sept. 11, at noon ET. Don’t miss the chance to share yo
TNR: Future Treatment of ILD
TNR: Future Treatment of ILD tammytilley@gm… Wed, 09/10/2025 – 10:39 Education/ACR/EULAR Anti-Rheumatic Rx Drug Safety Novel Rx Other Rheumatoid Arthritis
RheumNow
Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Scleros
Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Scleros https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 09/10/2025 – 10:01
RheumNow
Stay sharp in RA, PsA & SpA care. Get the latest breakthroughs + expert insights at RWCS 2026. Don’t miss ‘Year in
Stay sharp in RA, PsA & SpA care. Get the latest breakthroughs + expert insights at RWCS 2026. Don’t miss
Lessons Learned in Neuropsychiatric SLE
Lessons Learned in Neuropsychiatric SLE tammytilley@gm… Wed, 09/10/2025 – 09:00 Lupus Education/ACR/EULAR Mental Health Dr. Sheila Reyes, The Philippines, reports
RheumNow
Antifibrotics – A New Class of Therapies in Rheumatology?
Antifibrotics – A New Class of Therapies in Rheumatology? shervin.assass… Wed, 09/10/2025 – 08:00
QD Clinic Video: RA and Bronchiectasis
QD Clinic Video: RA and Bronchiectasis tammytilley@gm… Wed, 09/10/2025 – 08:00 Rheumatoid Arthritis Cardio/Pulmonary Outcomes Dr. Jeffrey Sparks, Boston, talks
RheumNow
Future Treatment of ILD https://t.co/UtAcAk00vq
Future Treatment of ILD https://t.co/UtAcAk00vq https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 09/09/2025 – 19:01 RheumNow Dr. John Cush Future Treatment of ILD https://t.co/UtAcAk00vq
RheumNow
Metanalysis of 7 studies (1979-2023) shows RA pts on vegetarian or vegan diets achieved no improvement in disease activ
Metanalysis of 7 studies (1979-2023) shows RA pts on vegetarian or vegan diets achieved no improvement in disease activ https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
SPRING-SIR Italian registry of systemic sclerosis: 1917 SSc pts, 56% had GI Sx, assoc w/ longer Dz duration, more severe
SPRING-SIR Italian registry of systemic sclerosis: 1917 SSc pts, 56% had GI Sx, assoc w/ longer Dz duration, more severe
RheumNow
ERS/EULAR guidelines for CTD-related interstitial lung disease
ERS/EULAR guidelines for CTD-related interstitial lung disease jjcush@gmail.com Tue, 09/09/2025 – 16:28
RheumNow
Where are we now—and where are we going in ILD treatment? 📅 September 9 (TONIGHT!)| ⏰ 7PM EST (LIVE) Rheumatolog
Where are we now—and where are we going in ILD treatment? 📅 September 9 (TONIGHT!)| ⏰ 7PM EST (LIVE) Rheumatolog
ILD: Background/Introduction (Part One)
ILD: Background/Introduction (Part One) tammytilley@gm… Tue, 09/09/2025 – 14:29 Image By downloading this material, I acknowledge that it may be
RheumNow
Obstructive sleep apnea in USA is expected to rise from 34·3% in 2020 to 46·2%, resulting in 76·6 million OSA cases b
Obstructive sleep apnea in USA is expected to rise from 34·3% in 2020 to 46·2%, resulting in 76·6 million OSA